Publications by authors named "Elijah Weber"

Claim this Profile
O
Optimal Design of Drug-Drug Interaction Studies for the GLP-1 Receptor Agonist Drug Class for Weight Management: Closing a Potential Data Gap.
Elijah Weber, Ashit Trivedi, April M Barbour

J Clin Pharmacol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic-Associated Fatty Liver Disease.
Islam R Younis, Elijah J Weber, Cara Nelson, Ann R Qin, Timothy R Watkins

J Clin Pharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Cilofexor and Firsocostat in Healthy Japanese and Non-Japanese Participants.
Islam R Younis, Cara Nelson, Elijah J Weber, Gong Shen, Ann R Qin

J Clin Pharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Firsocostat, a Liver-Targeted Inhibitor of Acetyl-CoA Carboxylase.
Elijah J Weber, Islam R Younis, Cara Nelson, Ann R Qin, Timothy R Watkins

Clin Pharmacokinet· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Firsocostat, an Acetyl-Coenzyme A Carboxylase Inhibitor, in Participants with Mild, Moderate, and Severe Hepatic Impairment.
Islam R Younis, Cara Nelson, Elijah J Weber, Ann R Qin, Timothy R Watkins

J Clin Pharmacol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Effects of Meal Type and Acid-Reducing Agents on the Pharmacokinetics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist.
Elijah J Weber, Islam R Younis, Lulu Wang, Deqing Xiao, William T Barchuk

Clin Pharmacol Drug Dev· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of long-acting lenacapavir in participants with hepatic or renal impairment.
Vamshi Jogiraju, Elijah Weber, Jason Hindman, Steve West, John Ling

Antimicrob Agents Chemother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Disposition, and Biotransformation of [C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous Infusion.
Elijah Weber, Raju Subramanian, William Rowe, Michael Graupe, John Ling

Clin Pharmacokinet· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Renal Impairment on the Pharmacokinetics of Firsocostat, an Acetyl-Coenzyme A Carboxylase Inhibitor, and Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist.
Elijah Weber, Islam R Younis, Cara Nelson, Dora Ding, Ann Qin

J Clin Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist.
Islam Younis, Elijah Weber, Cara Nelson, Brian J Kirby, Gong Shen

Clin Pharmacokinet· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In This Together: Navigating Ethical Challenges Posed by Family Clustering during the Covid-19 Pandemic.
Nicole R Van Buren, Elijah Weber, Mark J Bliton, Thomas V Cunningham

Hastings Cent Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A High-Throughput Screen Identifies DYRK1A Inhibitor ID-8 that Stimulates Human Kidney Tubular Epithelial Cell Proliferation.
Maria B Monteiro, Susanne Ramm, Vidya Chandrasekaran, Sarah A Boswell, Elijah J Weber

J Am Soc Nephrol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity.
Elijah J Weber, Kevin A Lidberg, Lu Wang, Theo K Bammler, James W MacDonald

JCI Insight· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technology Transfer of the Microphysiological Systems: A Case Study of the Human Proximal Tubule Tissue Chip.
Courtney Sakolish, Elijah J Weber, Edward J Kelly, Jonathan Himmelfarb, Roula Mouneimne

Sci Rep· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reframing Medical Appropriateness: A Case Study Concerning the Use of Life-Sustaining Technologies for a Patient With Profoundly Diminished Quality of Life.
Colleen M Gallagher, Elijah Weber, Nisha Rathi

Narrat Inq Bioeth· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity.
Shih-Yu Chang, Elijah J Weber, Viktoriya S Sidorenko, Alenka Chapron, Catherine K Yeung

JCI Insight· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microphysiological Systems to Assess Nonclinical Toxicity.
Kirk P Van Ness, Shih-Yu Chang, Elijah J Weber, Danielle Zumpano, David L Eaton

Curr Protoc Toxicol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concise Review: Current and Emerging Biomarkers of Nephrotoxicity.
Elijah J Weber, Jonathan Himmelfarb, Edward J Kelly

Curr Opin Toxicol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a microphysiological model of human kidney proximal tubule function.
Elijah J Weber, Alenka Chapron, Brian D Chapron, Jenna L Voellinger, Kevin A Lidberg

Kidney Int· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moral Distress, Workplace Health, and Intrinsic Harm.
Elijah Weber

Bioethics· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro.
Melanie Adler, Susanne Ramm, Marc Hafner, Jeremy L Muhlich, Esther Maria Gottwald, Elijah Weber

J Am Soc Nephrol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis